| Application no. and date | 12712104.4 (espacenet) (Federated) (European Patent Register), 20120329 | | Patent/reg. no. and date | DK/EP 2694508, 20141119 | | Publication date | 20140212 | | Priority no. and date | EP 11161111, 20110405 | | EP pub. no. and date |
EP 2694508 20140212 | | Effective date | | | Applicant/owner | Bayer Intellectual Property GmbH, Alfred-Nobel-Str. 50
40789 Monheim am Rhein, DE | | Applicant ref. no. | BHC103074 | | Inventor | Militzer, Hans-Christian, Waldweg 2
51519 Odenthal, DE,
MÜLLER, Hartwig, Wiesenweg 10
42553 Velbert, DE,
PETERS, Jan, Georg, Belliniweg 6
42719 Solingen, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61P 35/00 (2006.01) , C07D 487/04 (2006.01) | | Title | SUBSTITUEREDE 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINSALTE | | Int. application no. | EP2012055600 | | Int. publication no. | WO2012136553 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
